TrialNature medicine2022

Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.

Richard D Carvajal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.